Association of White Matter Hyperintensities with Low Serum 25-Hydroxyvitamin D Levels

References

1. 1.↵
   1. Miller JW

   . Vitamin D and cognitive function in older adults: are we concerned about vitamin D-mentia? Neurology 2012;74:13–15
2. 2.↵
   1. Brody J

   . Reasons that vitamin D may matter. The New York Times. March 13, 2012; D7
3. 3.↵
   1. Holick MF

   . Vitamin D deficiency. N Engl J Med 2007;357:266–81

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Annweiler C,
   2. Schott AM,
   3. Allali G,
   4. et al

   . Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010;74:27–32

   CrossRef
5. 5.↵
   1. Niino M

   . Vitamin D metabolites and multiple sclerosis. J Neurol Neurosurg Psychiatry 2011;82:121

   FREE Full Text
6. 6.↵
   1. Weinstock-Guttman B,
   2. Zivadinov R,
   3. Qu J,
   4. et al

   . Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients. J Neurol Neurosurg Psychiatry 2011;82:189–95

   Abstract/FREE Full Text
7. 7.↵
   1. Fernandes de Abreu DA,
   2. Nivet E,
   3. Baril N,
   4. et al

   . Developmental vitamin D deficiency alters learning in C57B1/6J mice. Behav Brain Res 2010;208:603–08

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Buell JS,
   2. Dawson-Hughes B,
   3. Scott TM,
   4. et al

   . 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010;74:18–26

   CrossRefPubMed
9. 9.↵
   1. Slinin Y,
   2. Paudel ML,
   3. Taylor BC,
   4. et al

   . 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010;74:33–41

   CrossRef
10. 10.↵
    1. Annweiler C,
    2. Fantino B,
    3. Schott AM,
    4. et al

    . Vitamin D insufficiency and mild cognitive impairment: cross-sectional association. Eur J Neurol 2012;19:1023–29

    CrossRefPubMed
11. 11.↵
    1. Llewellyn DJ,
    2. Lang IA,
    3. Langa KM,
    4. et al

    . Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010 170:1135–41

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Mowry E,
    2. Waubant E,
    3. McCulloch C,
    4. et al

    . Vitamin D status predicts new brain MRI activity in multiple sclerosis. Ann Neurol 2012;72:234–40

    CrossRefPubMed
13. 13.↵
    1. van den Heuvel DM,
    2. ten Dam VH,
    3. de Craen AJ,
    4. et al

    . Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J Neurol Neurosurg Psychiatry 2006;77:149–53

    Abstract/FREE Full Text
14. 14.↵
    1. Yoshita M,
    2. Fletcher E,
    3. Harvey D,
    4. et al

    . Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD. Neurology 2006;67:2192–98

    CrossRef
15. 15.↵
    1. Inzitari D,
    2. Simoni M,
    3. Pracucci G,
    4. et al

    . Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007;167:81–88

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Gouw AA,
    2. van der Flier WM,
    3. Fazekas F,
    4. et al

    . Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability Study. Stroke 2008;39:1414–20

    Abstract/FREE Full Text
17. 17.↵
    1. Debette S,
    2. Bombois S,
    3. Bruandet A,
    4. et al

    . Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007;38:2924–30

    Abstract/FREE Full Text
18. 18.↵
    1. Vannorsdall TD,
    2. Waldstein SR,
    3. Kraut M,
    4. et al

    . White matter abnormalities and cognition in a community sample. Arch Clin Neuropsychol 2009;24:209–17

    Abstract/FREE Full Text
19. 19.↵
    1. Maillard P,
    2. Carmichael O,
    3. Harvey D,
    4. et al

    . FLAIR and diffusion MRI signals are independent predictors of white matter hyperintensities. AJNR Am J Neuroradiol 2013;34:54–61

    Abstract/FREE Full Text
20. 20.↵
    1. Schmidt R,
    2. Enzinger C,
    3. Ropele S,
    4. et al

    . Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study. Lancet 2003;361:2046–48

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Knopman D,
    2. Boland LL,
    3. Mosley T,
    4. et al

    . Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;6:42–48
22. 22.↵
    1. Akisaki T,
    2. Sakurai T,
    3. Takata T,
    4. et al

    . Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging: Japanese Elderly Diabetes Intervention Trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376–84

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Annweiler C,
    2. Montero-Odasso M,
    3. Muir SW,
    4. et al

    . Vitamin D and brain imaging in the elderly: should we expect some lesions specifically related to hypovitaminosis D? Open Neuroimaging Journal 2012;6:16–18

    CrossRefPubMed
24. 24.↵
    1. Chaudhuri A

    . Why we should offer routine vitamine D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 2005;64:608–18

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Rajakumar K,
    2. Greenspan SL,
    3. Thomas SB,
    4. et al

    . Solar ultraviolet radiation and vitamin D: a historical perspective. Am J Public Health 2007;97:1746–54

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Murray AK,
    2. Staff RT,
    3. Shenkin SD,
    4. et al

    . Brain white matter hyperintensities: relative importance of vascular risk factors in nondemented elderly people. Neurology 2005;237:251–57
27. 27.↵
    1. Swan GE,
    2. DeCarli C,
    3. Miller BL,
    4. et al

    . Association of midlife blood pressure to late-life congnitive decline and brain morphology. Neurology 1998;51:986–93

    CrossRef
28. 28.↵
    1. Valdés Hernández MC,
    2. Piper RJ,
    3. Bastin ME,
    4. et al

    . Morphologic, distributional, volumetric, and intensity characterization of ventricular hyperintensities. AJNR Am J Neuroradiol 2014;35:55–62

    Abstract/FREE Full Text
29. 29.↵
    1. Knopman DS,
    2. Penman AD,
    3. Catellier DJ,
    4. et al

    . Vascular risk factors and longitudinal changes on brain MRI. Neurology 2011;76:1879–85

    CrossRef
30. 30.↵
    1. Filippi M,
    2. Rocca MA

    . MR imaging of multiple sclerosis. Radiology 2011;259:659–81

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Stahl R,
    2. Dietrich O,
    3. Teipel SJ,
    4. et al

    . White matter damage in Alzheimer disease and mild cognitive impairment: assessment with diffusion-tensor MR imaging and parallel imaging techniques. Radiology 2007;243:483–92

    CrossRefPubMedWeb of Science